Name |
Nanocarrier |
Clinical Status |
Compound |
References |
DaunoXome |
Liposome |
Approved |
Daunorubicin |
50, 56 |
Doxil/Caelyx |
Liposome |
Approved |
Doxorubicin |
2, 50, 56 |
CPX-1 |
Liposome |
P1 |
Irinotecan |
4 |
LE-SN38 |
Liposome |
P2 |
SN-38 |
31 |
MCC465 |
Ab- liposome |
P1 |
Doxorubicin |
38 |
NK911 |
Micelle |
P1 |
Doxorubicin |
27, 56 |
SP1049C |
Micelle |
P3 |
Doxorubicin |
9, 27, 53 |
NK105 |
Micelle |
P2 |
Paclitaxel |
24 |
NC-6004 |
Micelle |
P1/2 |
Cisplatin |
57 |
Zoladex* |
Polymer rods |
Approved |
Goserelin acetate |
12 |
Lupron Depot* |
Polymer microspheres |
Approved |
Leuprolide acetate |
1, 12 |
Oncaspar |
PEG |
Approved |
L-Asparaginase |
11 |
PEG intron |
PEG |
Approved |
α-Interferon |
7 |
Zinostatin |
Polymer |
Approved |
SMANCS** |
42 |
PK1 |
HPMA copolymer |
P2/3 |
Doxorubicin |
48 |
Abraxane |
Albumin |
Approved |
Paclitaxel |
39 |
Ontak |
IL2 Fusion Protein |
Approved |
Diptheria toxin |
15, 16 |
Zevalin |
Anti-CD20 |
Approved |
Yttrium-90/Indium-111 |
20 |
Bexxar |
Anti-CD20 |
Approved |
Iodine-131 |
20 |
*Polymers composed of polylactide-co-glycolide.
**Styrene maleic anhydride neocarzinostatin. |